Results 131 to 140 of about 914,390 (333)
FDA arthritis advisory committee meeting: Expanded role for committee members; guidelines on analgesics [PDF]
, 1991 Harold E. Paulus
openalex +1 more source
What About the Children? - FDA's Response to Pediatric Drug Testing [PDF]
, 2012 The Federal Food and Drug Administration (FDA) has played a critical role in the protection of human subjects in research. Most recently, FDA enacted an interim final rule regarding protection of children in clinical investigations.
Doerner, Kristina M.
core
Advanced Functional Materials, EarlyView.Shellac, a centuries‐old natural resin, is reimagined as a green material for flexible electronics. When combined with silver nanowires, shellac films deliver transparency, conductivity, and stability against humidity. These results position shellac as a sustainable alternative to synthetic polymers for transparent conductors in next‐generation ...
Rahaf Nafez Hussein +4 more
wiley +1 more source
Regulatory Science Needs for Neonates: A Call for Neonatal Community Collaboration and Innovation
Frontiers in Pediatrics, 2014 Susan K McCune, Yeruk Ager Mulugeta
doaj +1 more source
FDA announces reforms of drug review process [PDF]
, 1991 Christopher Anderson
openalex +1 more source
DENTA: A Dual Enzymatic Nanoagent for Self‐Activating Tooth Whitening and Biofilm Disruption
Advanced Functional Materials, EarlyView.The nanoapatite with dual enzymes (DENTA) accumulates in dentinal tubules, reducing hypersensitivity caused by dental nerve exposure and facilitating continuous ROS generation through salivary glucose for effective, long‐term whitening. The dentin structures remain non‐destructive due to the low concentration of ROS, demonstrating excellent cell ...
Junseok Kim +13 more
wiley +1 more source
Nature CommunicationsCurrently, only Palivizumab and Nirsevimab that target the respiratory syncytical virus (RSV) fusion protein are licensed for pre-treatment of infants. Glycoprotein-targeting antibodies may also provide protection against RSV.
Youri Lee +5 more
doaj +1 more source
Process development for production of non-originator NISTmAb from CHO and NS0 cell lines
mAbsCell lines that produce non-originator versions of the National Institute of Standards and Technology (NIST) monoclonal antibody reference material 8671 (NISTmAb) are invaluable to the biopharmaceutical industry because, unlike typical commercial cell ...
Erica J. Fratz-Berilla +4 more
doaj +1 more source